Market Overview The CGRP Antagonists Market is expanding rapidly as calcitonin gene-related peptide-targeted therapies transform migraine treatment and prevention. Unlike older, broadly acting medications, these targeted therapies address the specific neuropeptide pathway implicated in migraine pathophysiology, offering improved efficacy and tolerability for chronic and episodic migraine...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt